What’s in the US Food and Drug Administration’s CBD Report to Congress?

The FDA is reopening public comment, collaborating with global regulators on how to handle cannabinoids, and backing research on CBD and “dermal penetration.”

CBD
Congress

A Political Mystery: The Cannabis Money Pushing to Keep the US Senate Red

The sudden push is puzzling, as cannabis legislation tends to move under House Democrats—and get stalled by Senate Republicans.

CBD

GW Pharmaceuticals and GNC met with White House on CBD

One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.